Press release
Asia-Pacific Respiratory Drug Market 2021-2027: Industry Analysis, Trends, Growth, Opportunities, and Forecast
Asia-Pacific respiratory drug market was $9.8 billion in 2018 and is anticipated to grow at a substantial rate of 7.9% during the forecast period. Major factors that augment the growth of the market include a large population base susceptible to asthma and COPD, rising awareness about treatment for asthma and COPD, and the significant presence of market players in the region. Asia-Pacific has a potential market due to the increasing R&D and investments by big pharmaceutical companies in life science research coupled with harnessing innovation. The respiratory drug market in the Asia-Pacific region presents future opportunities for growth as the prevalence of respiratory diseases such as asthma, COPD in emerging economies such as India and China. In addition, increasing the geriatric population specially in Japan is another major reason for the growing market.To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-respiratory-drug-market
The major economies that are contributing to the regional business growth of the market include China, Japan, India, and others. The Asia-Pacific respiratory drug market is segmented on the basis of the route of administration, application, and end-user. Based on the route of administration, the market is classified into oral, injectable, and inhalable. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. The asthma disease application segment dominated the regional market in 2018 and is further estimated to follow the same trend over the forecast period. This is mainly due to the high prevalence of asthma in the economies of the region such as China, Japan, India, and Others.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/asia-pacific-respiratory-drug-market
Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing respiratory drugs to cater to a wide range of customers within and outside the region. The major players of the Asia-Pacific respiratory drug market include Takeda Pharmaceutical Company Ltd., Cipla Ltd., AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, and Teva Pharmaceuticals Industries Ltd. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players.
Market Segmentation
Asia-Pacific Respiratory Drug Market by Route of Administration
• Oral
• Injectable
• Inhalable
Asia-Pacific Respiratory Drug Market by Application
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
Asia-Pacific Respiratory Drug Market by End-User
• Homecare
• Hospitals and Clinics
Regional Analysis
• China
• Japan
• India
• Rest of Asia-Pacific
Company Profiles
• Air Liquide S.A.
• Aradigm Corp.
• AstraZeneca PLC
• Baxter International Inc.
• Boehringer Ingelheim International GmbH
• Cipla Ltd.
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline PLC
• Merck & Co.
• Novartis AG
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-respiratory-drug-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia-Pacific Respiratory Drug Market 2021-2027: Industry Analysis, Trends, Growth, Opportunities, and Forecast here
News-ID: 2374800 • Views: …
More Releases from Orion Market Research
Sterile Solution for Injection Market Size, Trends, Latest Insights, Analysis an …
The global Sterile Solution for Injection Market is expected to grow at a significant CAGR during the forecast period. The sterilized solution is used to mix infant formula for babies, dilute or dissolve water-soluble medications for injections, and mix infant formula for persons with impaired immune systems. It is mostly utilised in medical settings since it cannot transmit infections. Although sterile water is occasionally distilled, it is not the same…
Stem Cell and Platelet Rich Plasma Alopecia Therapies Market Analysis and Future …
The global stem cell and platelet rich plasma alopecia therapies market is expected to grow at a significant CAGR during the forecast period. Increased need for accurate and rapid alopecia treatment, as well as breakthroughs in platelet rich plasma and stem cell therapies that have transformed diagnostic technology, which is expected to drive the market forward. Furthermore, the global market is likely to be driven by an increase in awareness…
STD Home Testing Market Size, Trends, Latest Insights, Analysis and Forecast 202 …
The global STD home testing market is anticipated to grow at a considerable CAGR of around 4.7% during the forecast period. More than 30 different bacteria, viruses, and parasites are transmitted through sexual contact. Eight of these pathogens are linked to the greatest incidence of sexually transmitted disease, which include syphilis, gonorrhea, Chlamydia, trichomoniasis, hepatitis B, herpes simplex virus, HIV, and human papillomavirus (HPV). According to the National Center for…
Staphylococcal Infection Drug Market Is Expected To Exhibit Significant Growth O …
The global staphylococcal infection drug market is expected to grow at a significant CAGR during the forecast period. The presence of single infectious staph in the environment can lead to an increase in the use of anti-staphylococcal medications among people. Staphylococcus infection is a form of bacterial infection that can live within the nose or on the skin. This disease is communicable, and it is the cause of an increase…
More Releases for COPD
Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing…
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's.
It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be…
COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
Access more details about this report at: https://www.research2reports.com/report-medical-devices/copd-therapeutics-market/80858
The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market…
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would…
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the…
Asthma and COPD Drugs Market: High Costs of Asthma and COPD Drugs and Consumer A …
Asthma is a disease characterized by recurrent attacks of coughing, chest-tightening, breathlessness, and wheezing as the airways narrow and swell that vary in severity and frequency. COPD is a disease of the lungs characterized by obstruction to airflow that interferes with normal breathing. According to the WHO, COPD accounted for over 3 million deaths in 2012, which is equal to 6% of all deaths globally in that year. Moreover, the…
